Charles Schoch - 26 Jan 2026 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role: Chief Financial Officer
Signature: /s/ Charles Schoch
Issuer symbol: CADL
Transactions as of: 26 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 28 Jan 2026, 17:02:42 UTC
Previous filing: 26 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Schoch Charles	Chief Financial Officer	C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM	/s/ Charles Schoch	28 Jan 2026	0002007349

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CADL	Stock Option (Right to Buy)	Award	$0	+232,000		$0.000000	232,000	26 Jan 2026	Common Stock	232,000	$6.01	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 26, 2026, subject to the Reporting Person's continued service on each vesting date.